Please wait...
Share Wealth
Home
Services
Research
Market
News
Download
Inviting Business Associates
Profile
Careers
Contact Us
Login
Open An Account
Copyright © 2010
Sharewealth Group of Companies.
Designed & Developed by
<
>
Market
Equity
Overview
Top Gainers
Top Losers
Top Volume
Top Value
Close Prices
52 Week High/Low
Indices
ADR-GDR Prices
Advance Decline
Forex
Holiday List
Market Commentary
DERIVATIVES
Derivatives Home
Top Gainers
Top Losers
Top Traded Volume
Top Traded Value
Highest in Premium
Most Active Calls
Most Active Puts
Most Active Contracts
Open Interest
Historical Data
FII Statistics
Get Quotes All
Get Quotes
Settlement Prices
Put Call Ratio
Underlying Info
Active Underlying Info
COMMODITY
Overview
Top Gainers
Top Losers
Top Volume
Top Value
Highest in OI
Lowest in OI
Increase in OI
Decrease in OI
Spot Gainers/Losers
Advances Declines
Market Breadth
Commodity News
Closing Prices
Search
Commodity Indices
IPO
Overview
Issue Profiles
Forthcoming IPO
Open Issues
Closed Issues
New Listing
IPO News
Basis of Allotment
Draft Prospectus
Comparative Study
MUTUAL FUND
MF Home
MF Gainers
MF Losers
Latest NAV
Forthcoming Issues
MF Open Issues
MF Closed Issues
Fund Mobilization
MF Activity
MF News
MF FAQs
Scheme Search
Scheme Profile
ANNOUNCEMENT
BSE Announcements
NSE Announcements
Board Meetings
Change of Company Names
AGM Details
Dividend Details
Bonus Details
Rights Details
Splits Details
Delisted Shares
FII Activity
MF Activity
My Easy Will
Markets Navigation
Equity
Derivatives
Company Info.
IPO
Announcement
Commodity
Mutual Fund
Currency
Company Info.
Live Quotes
Company Profile
Locations
Shareholding Pattern
Products & Raw Material
Management Team
Director's Report
Company News
Income Statement
Balance Sheet
Ratios Analysis
Cash Flow
High Low
Technical Charting
Company Meetings
Investor Returns
Bal Pharma Ltd.
Live Quotes
Registered Address
Registered Office & Factory : # 21 & 22, Bommasandra Industrial Area, , Hosur Road,
Bengaluru, Karnataka - 560099
Tel: 080-22354057
Fax: 080-41570820
Email :
info@balpharma.com
Website :
http://www.balpharma.com
Key Officials
Name
Designation
Mr. D V Bharath Bhushan
Chief Financial Officer
Mr. Abdul Basith
Co. Secretary & Compl. Officer
Listings
BSE , MCXSX , NSE
Corporate News
Bal Pharma Ltd - Scheme of Arrangement
Bal Pharma Ltd - Announcement under Regulation 30 (LODR)-Sch...
Bal Pharma Ltd - Trading Window-XBRL
Bal Pharma Ltd - Trading Window
Bal Pharma Ltd - Withdrawal Of Promoter Reclassification Req...
Bal Pharma Ltd - General Updates
Bal Pharma Ltd - Updates
Bal Pharma Ltd - Copy of Newspaper Publication
Bal Pharma Ltd - Integrated Filing- Financial
Bal Pharma Ltd - Integrated Filing (Financial)
Board Meetings
Date
Purpose
13/02/2025
Quarterly Results & Fund Raising
14/11/2024
Quarterly Results
12/08/2024
Quarterly Results, ESOP & A.G.M.
Share Holding Pattern as on 31/12/2024
Major Holder
No. of Shares
Percentage(%)
Promoters
8,097,182
50.86
Institutional Investors
21,822
0.14
Other Investors
2,615,988
16.43
General Public
5,185,880
32.57
Registrar Details
MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West)
Mumbai,400083,Maharashtra
Tel :
022-49186270
Fax :
49186060
Today's Market
BSE
Market Performance
Exchange
BSE
NSE
Last Traded Price (
`
)
115.50
115.36
Last Traded Date
04/04/2025
04/04/2025
Last Traded Time
09:56:00 AM
09:44:55 AM
Change (%)
5.92%
6.48%
Day's Open (
`
)
114.24
114.95
Previous Close (
`
)
109.04
108.34
Day's High (
`
)
123.50
121.80
Day's Low (
`
)
113.26
113.02
Total Traded Qty
31770
527125
Value (
`
In Lacs)
36.69
622.75
Bid Price (
`
)
115.12
115.36
Bid Quantity
47
181
Offer Price (
`
)
115.49
115.74
Offer Quantity
500
185
Exchange Code
524824
BALPHARMAEQ
Exchange Group
B
OtherEQ
Bal Pharma Ltd.
Company Profile
BAL PHARMA LTD.
Market Cap.(
`
)
183.66 Cr.
P/BV
2.67
Book Value (
`
)
43.21
52 Week High/Low (
`
)
158/78
FV/ML
10/1
P/E(X)
24.85
Book Closure
25/09/2024
EPS (
`
)
4.64
Div Yield (%)
1.04
Registered Office
Registered Office & Factory : # 21 & 22, Bommasandra Industrial Area, , Hosur Road,,
Bengaluru, Karnataka - 560099
Tel: 080-22354057,Fax: 080-41570820
Website :
http://www.balpharma.com
Email :
info@balpharma.com
Registrar & Share Transfer Agent
MUFG Intime India Pvt. Ltd.
C 101, 247 Park, L.B.S. Marg, Vikhroli (West), , , Mumbai - 400083, Maharashtra
Tel : 022-49186270, 49186200 Fax : 49186060
Recent News
Headline
Date
Bal Pharma Ltd - Scheme of Arrangement
28/03/2025
Bal Pharma Ltd - Announcement under Reg...
28/03/2025
Bal Pharma Ltd - Trading Window-XBRL
25/03/2025
Bal Pharma Ltd - Trading Window
25/03/2025
View More
Other Details
Business Group
Micro Lab Group
BSE Code
524824
NSE Code
BALPHARMAEQ
Listings
BSE , MCXSX , NSE
ISIN No.
INE083D01012
Attention Investors :
“Prevent unauthorized transactions in your account ? Update your Mobile Numbers/Email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your Mobile/Email at the end of the day. Issued in the interest of Investors” ***** No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account. | | ***** KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (Broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary. |
"Revised guidelines on margin collection
==> 1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. | 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. | 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. | 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. | 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. .......... Issued in the interest of Investors" | ***** MEMBERS : SEBI Regn. No: NSE, BSE: INZ000176636 ; MCX : INZ000057535; SEBI Research Analyst Regn No: INH200000337; AMFI Regn No. 77624; Depository Participant : CDSL : IN-DP-CDSL-379-2006 DP ID : 12047600 | For any Grievance mail to : grievance@sharewealthindia.com | For any DP Grievance mail to : dpgrievance@sharewealthindia.com. | Grievance with SEBI :
https://scores.gov.in/scores/Welcome.html
Investor Protection
BSE
NSE
MCX
Investor Safeguards
BSE
NSE
MCX
Disclaimer